Noema Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Noema Pharma's estimated annual revenue is currently $7.8M per year.
- Noema Pharma's estimated revenue per employee is $189,024
- Noema Pharma's total funding is $210M.
Employee Data
- Noema Pharma has 41 Employees.
- Noema Pharma grew their employee count by 11% last year.
Noema Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Head Clinical Operations | Reveal Email/Phone |
3 | EVP Research & Development | Reveal Email/Phone |
4 | VP, CMC & Clinical Supply | Reveal Email/Phone |
5 | Director Clinical Operations, Noema Pharmaceuticals | Reveal Email/Phone |
6 | Director Strategy and Business Development | Reveal Email/Phone |
7 | Director Clinical Operations | Reveal Email/Phone |
8 | Clinical Trial Associate | Reveal Email/Phone |
9 | Senior Clinical Trial Associate | Reveal Email/Phone |
10 | Interim Head Clinical Development Operations | Reveal Email/Phone |
Noema Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Noema Pharma?
Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema's research and development is focused on understanding and meeting patient needs using our novel therapies.
keywords:N/A
$210M
Total Funding
41
Number of Employees
$7.8M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Noema Pharma News
2022-04-13 - PDE10A Inhibition in Tourette Syndrome
In 2021, Noema Pharma in-licensed the PDE10A inhibitor NOE-105 from Roche12,13 for a clinical study of this drug candidate in reducing the...
2022-03-22 - Noema Pharma to Attend and Present at Stifel 2022 CNS Days
BASEL, Switzerland, March 25, 2022 (GLOBE NEWSWIRE) -- Noema Pharma, a Swiss-based clinical-stage company targeting orphan and large-market...
Other Companies in Basel
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.4M | 41 | 21% | N/A |
#2 | $5.1M | 44 | 22% | $17M |
#3 | $8.9M | 44 | 7% | N/A |
#4 | $7.7M | 44 | -30% | N/A |
#5 | $6.7M | 48 | 9% | N/A |